% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Xu:157225,
author = {X. Xu$^*$ and M. Fallah$^*$ and Y. Tian$^*$ and T.
Mukama$^*$ and K. Sundquist and J. Sundquist and H.
Brenner$^*$ and E. Kharazmi$^*$},
title = {{R}isk of invasive prostate cancer and prostate cancer
death in relatives of patients with prostatic borderline or
in situ neoplasia: {A} nationwide cohort study.},
journal = {Cancer},
volume = {126},
number = {19},
issn = {0008-543X},
address = {New York, NY},
publisher = {Wiley-Liss},
reportid = {DKFZ-2020-01495},
pages = {4371-4378},
year = {2020},
note = {2020 Oct 1;126(19):4371-4378#EA:C120#LA:C120#},
abstract = {The question of whether having a family history of
prostatic borderline or in situ neoplasia (PBISN) is
associated with an increased risk of invasive prostate
cancer (PCa) or death from PCa remains unanswered. The
objective of the current study was to provide an
evidence-based risk estimation for the relatives of patients
with PBISN.Nationwide Swedish family cancer data sets were
used for the current study, including data regarding all
residents of Sweden who were born after 1931 and their
parents. Standardized incidence ratios (SIRs), standardized
mortality ratios (SMRs), and lifetime cumulative risks of
PCa were calculated for men with different constellations of
family history. Family history was defined as a dynamic
(time-dependent) variable considering changes during
follow-up (1958-2015).Of the 6,343,727 men in the current
study, a total of 238,961 developed invasive PCa and 5756
were diagnosed with PBISN during the follow-up. Men with 1
first-degree relative who was diagnosed with PBISN had a
$70\%$ increased risk of invasive PCa (SIR, 1.7; $95\%$
confidence interval, 1.5-1.9) and PCa death (SMR, 1.7;
$95\%$ confidence interval, 1.3-2.2) compared with men with
no family history of PBISN or invasive PCa. These were
rather close to estimates in men with 1 first-degree
relative diagnosed with invasive PCa (SIR, 2.1 and SMR,
1.8). A higher risk of PCa in family members was found among
patients with a family history of PBISN and/or PCa diagnosed
before age 60 years. The results in terms of cumulative risk
resembled this trend.A family history of PBISN appears to be
as important as a family history of invasive PCa with regard
to an increased risk of invasive PCa or PCa mortality. Such
a history should not be overlooked in PCa screening
recommendations or in future research regarding familial
PCa.},
cin = {C120 / C070 / HD01},
ddc = {610},
cid = {I:(DE-He78)C120-20160331 / I:(DE-He78)C070-20160331 /
I:(DE-He78)HD01-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:32697345},
doi = {10.1002/cncr.33096},
url = {https://inrepo02.dkfz.de/record/157225},
}